State Street’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.65M | Buy |
|
|||||
|
2025
Q2 | $1.62M | Sell |
|
|||||
|
2025
Q1 | $1.8M | Buy |
|
|||||
|
2024
Q4 | $3M | Buy |
|
|||||
|
2024
Q3 | $2.11M | Buy |
|
|||||
|
2024
Q2 | $3.48M | Buy |
|
|||||
|
2024
Q1 | $4.77M | Sell |
|
|||||
|
2023
Q4 | $6.87M | Sell |
|
|||||
|
2023
Q3 | $32.9M | Buy |
|
|||||
|
2023
Q2 | $10.9M | Sell |
|
|||||
|
2023
Q1 | $41.7M | Sell |
|
|||||
|
2022
Q4 | $53.7M | Buy |
|
|||||
|
2022
Q3 | $49.1M | Sell |
|
|||||
|
2022
Q2 | $46.2M | Buy |
|
|||||
|
2022
Q1 | $66.7M | Buy |
|
|||||
|
2021
Q4 | $61M | Sell |
|
|||||
|
2021
Q3 | $64.8M | Sell |
|
|||||
|
2021
Q2 | $70.2M | Buy |
|
|||||
|
2021
Q1 | $70.6M | Buy |
|
|||||
|
2020
Q4 | $80.3M | Buy |
|
|||||
|
2020
Q3 | $78.8M | Sell |
|
|||||
|
2020
Q2 | $92.4M | Buy |
|
|||||
|
2020
Q1 | $56.8M | Buy |
|
|||||
|
2019
Q4 | $62.8M | Buy |
|
|||||
|
2019
Q3 | $56.4M | Buy |
|
|||||
|
2019
Q2 | $53.9M | Buy |
|
|||||
|
2019
Q1 | $30.4M | Sell |
|
|||||
|
2018
Q4 | $23.9M | Buy |
|
|||||
|
2018
Q3 | $36M | Buy |
|
|||||
|
2018
Q2 | $29.5M | Buy |
|
|||||
|
2018
Q1 | $21.2M | Sell |
|
|||||
|
2017
Q4 | $18.5M | Buy |
|
|||||
|
2017
Q3 | $25M | Buy |
|
|||||
|
2017
Q2 | $20.3M | Buy |
|
|||||
|
2017
Q1 | $23.6M | Buy |
|
|||||
|
2016
Q4 | $26.8M | Buy |
|
|||||
|
2016
Q3 | $21.5M | Buy |
|
|||||
|
2016
Q2 | $7.75M | Buy |
|
|||||
|
2016
Q1 | $7.92M | Buy |
|
|||||
|
2015
Q4 | $8.42M | Buy |
|
|||||
|
2015
Q3 | $7.15M | Buy |
|
|||||
|
2015
Q2 | $7.63M | Buy |
|
|||||
|
2015
Q1 | $2.47M | Buy |
|
|||||
|
2014
Q4 | $537K | Buy |
|